UC Berkeley
The company's DETECTR disease detection platform will be used to help develop the technology and optimize the CRISPR enzymes used in the point-of-care device.
The two new tests, which have the capability to quantify a patient's viral load, have been designed without external RNA extraction or amplification steps.
CRISPR Startup Metagenomi Raises $65M in Series A Financing Round
The company will use the funding to expand its gene editing systems for potential therapeutic use, and to advance research and validation for its pipeline.
The newly public company has attracted attention from both investors and competitors for its technology platform used in antibody discovery workflows.
Ansa Biotechnologies Raises $7.9M in Seed Funding
The funding will allow the company to accelerate development of its DNA synthesis technology, hire staff, build an R&D facility, and establish industrial partnerships.